crataegus complex
spagyros ag - washington, tm, 26.5 %; solidago virgaurea, tm, 7.5 %; valeriana officinalis d1, 3.5 %; valeriana officinalis, tm, 3.5 %; sanguisorba officinalis, tm, 7.5 %; solidago virgaurea d1, 7.5 %; sanguisorba officinalis, d1, 7.5 %; löwenzahn officinale, tm, 5.0 %; washington, d1, 26.5 %; löwenzahn officinale, d1, 5.0 % - tropfen / spray - d - crataegus, tm, 26.5 %; solidago virgaurea, tm, 7.5 %; valeriana officinalis, tm, 3.5 %; valeriana officinalis, d1, 3.5 %; sanguisorba officinalis, tm, 7.5 %; solidago virgaurea, d1, 7.5 %; sanguisorba officinalis, d1, 7.5 %; taraxacum officinale, tm, 5.0 %; crataegus, d1, 26.5 %; taraxacum officinale, d1, 5.0 % - homöopathisch-spagyrisch
crataegus 33%/onopordon comp. 5% aa dilutio
weleda ag - washington ethanol. verdauung tm, onopordon blume, frische, primulae blume, frische, hyoscyamus niger aus pflanzen-tm - dilutio - washington ethanol. verdauung tm 500 mg, verdauung ethanolica 50 mg onopordon blume frisch 12.5 mg, ratio: 1:3.1, verdauung ethanolica 50 mg primulae blume frisch 12,5 mg und hyoscyamus niger, von der pflanze tm 1 mg, ratio: 1:3.1, die lösung pro 1 g, endwerte. ethanolum 38 % v/v. - ohne indikation - anthroposophika
strophanthus composé
sérolab sa - washington, c4, 16.66 %; natrium tetrachloroauratum, g6, 16.66 %; selenicereus grandiflorus, d5, 16.66 %; strophanthus hispidus, d4, 16.66 %; camphora, d2, 16.66 %; valeriana officinalis, tm, 16.66 % - globuli, tabletten, trituration / pulver, tropfen / spray, trinkampullen, sonstige oral, granula - d - homöopathisch
crataegus laevigata
phytomed ag - washington laevigata - oral - tm, d1 - tropfen / spray
crataegus laevigata
spagyros ag - washington laevigata - oral - d1 - tropfen / spray
crataegus laevigata
laboratoire homéopathique d. schmidt-nagel sa - washington laevigata - oral - tm, d1 - tropfen / spray
crataegus laevigata
lrk laboratoire homéopathique de recherches kurtoglu sa - washington laevigata - oral - tm, d1 - tropfen / spray
fluarix tetra 15 µg / 0.5 ml injektionssuspension
glaxosmithkline ag - haemagglutininum influenzae a (h1n1) (virus stamm a/guangdong-maonan/swl1536/2019 (h1n1)-like: reassortant virus cnic-1909 derived from a/guangdong-maonan/swl1536/2019), haemagglutininum influenzae a (h3n2) (virus stamm a/hong kong/2671/2019 (h3n2)-like: reassortant virus nib-121 derived from a/hong kong/2671/2019), haemagglutininum influenzae b (virus stamm b/washington/02/2019-like: reassortant virus b/washington/02/2019 (victoria lineage)) - injektionssuspension - haemagglutininum influenzae a (h1n1) (virus stamm a/guangdong-maonan/swl1536/2019 (h1n1)-like: reassortant virus cnic-1909 derived from a/guangdong-maonan/swl1536/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus stamm a/hong kong/2671/2019 (h3n2)-like: reassortant virus nib-121 derived from a/hong kong/2671/2019) 15 µg, haemagglutininum influenzae b (virus stamm b/washington/02/2019-like: reassortant virus b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus stamm b/phuket/3073/2013 (yamagata lineage)) 15 µg, polysorbatum 80, octoxinolum-10, natrii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alpha-tocopheroli hydrogenosuccinas, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml, residui: ovalbuminum, formaldehydum, natrii desoxycholas, gentamicini sulfas, hydrocortisonum. - aktive immunisierung gegen influenza, ab 36 monaten - impfstoffe
vaxigriptetra suspension zur injektion in einer fertigspritze
sanofi-aventis (suisse) sa - haemagglutininum influenzae a (h1n1) (virus souche a/guangdong-maonan/swl1536/2019 (h1n1)-pdm09: reassortant virus cnic-19 derived from a/guangdong-maonan/swl1536/2019), haemagglutininum influenzae a (h3n2) (virus souche a/hong kong/2671/2019 (h3n2)-like: reassortant virus ivr-208 derived from a/hong kong/2671/2019), haemagglutininum influenzae b (virus souche b/washington/02/2019 (victoria lineage)) - suspension zur injektion in einer fertigspritze - haemagglutininum influenzae a (h1n1) (virus souche a/guangdong-maonan/swl1536/2019 (h1n1)-pdm09: reassortant virus cnic-19 derived from a/guangdong-maonan/swl1536/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus souche a/hong kong/2671/2019 (h3n2)-like: reassortant virus ivr-208 derived from a/hong kong/2671/2019) 15 µg, haemagglutininum influenzae b (virus souche b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus souche b/phuket/3073/2013 (yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.72 mg, kalium 0.08 mg, residui: formaldehydum, octoxinolum-9, neomycinum, ovalbuminum. - aktive immunisierung gegen influenza, ab dem 6. monat - impfstoffe
influvac tetra 0.5 ml injektionssuspension
mylan pharma gmbh - haemagglutininum influenzae a (h1n1) (virus-stamm a/guangdong-maonan/swl1536/2019 (h1n1)-pdm09: reassortant virus cnic-1909 derived from a/guangdong-maonan/swl1536/2019), haemagglutininum influenzae a (h3n2) (virus-stamm a/hong kong/2671/2019 (h3n2)-like: reassortant virus ivr-208 derived from a/hong kong/2671/2019), haemagglutininum influenzae b (virus-stamm b/washington/02/2019 (victoria lineage)) - injektionssuspension - haemagglutininum influenzae a (h1n1) (virus-stamm a/guangdong-maonan/swl1536/2019 (h1n1)-pdm09: reassortant virus cnic-1909 derived from a/guangdong-maonan/swl1536/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus-stamm a/hong kong/2671/2019 (h3n2)-like: reassortant virus ivr-208 derived from a/hong kong/2671/2019) 15 µg, haemagglutininum influenzae b (virus-stamm b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus-stamm b/phuket/3073/2013 (yamagata lineage)) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 2.0 mg, kalium 0.1 mg, residui: cetrimidum, formaldehydum, gentamicini sulfas, polysorbatum 80, ovalbuminum. - aktive immunisierung gegen influenza, ab 3 jahren - impfstoffe